oktober 9, 2020
Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 9 October 2020: Acacia Pharma Group plc (“Acacia Pharma”, the “Group”...


Eske Willerslev får stor norsk videnskabspris for Lundbeckfonden-forskning i hjernesygdomme
22. januar 2021
Danskere med gigt har gemt sig for coronavirus
20. januar 2021
Lundbeckfonden øger sit engagement i IO Biotech
12. januar 2021


Lundbeckfonden Ventures

Lundbeckfonden Emerge